Early research (Phase 1)Study completedNCT03002025
What this trial is testing
Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants
Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 48